May 23, 2005

12 Min Read
Women's Health References


May 23, 2005 - Natural Products Industry INSIDER
"Women's Health" References

1. Shamberger RJ. "Calcium, magnesium, and other elements in the redblood cells and hair of normals and patients with premenstrual syndrome." BiolTrace Elem Res. 94, 2:123-9, 2003. www.humanapress.com

2. Bendich A. "Micronutrients in women's health and immunefunction." Nutrition. 17, 10:858-67, 2001. www.journals.elsevierhealth.com/periodicals/nut

3. Fugh-Berman A, Kronenberg F. "Complementary and alternative medicine(CAM) in reproductive-age women: a review of randomized controlled trials."Reprod Toxicol. 17, 2:137-52, 2003. www.elsevier.nl/inca/publications/store/5/2/5/4/8/9

4. De Souza MC et al. "A synergistic effect of a daily supplement for 1month of 200 mg magnesium plus 50 mg vitamin B6 for the relief ofanxiety-related premenstrual symptoms: a randomized, double-blind, crossoverstudy." J Womens Health Gend Based Med. 9, 2:131-9, 2000.

5. Ziaei S, Zakeri M, Kazemnejad A. "A randomized controlled trial ofvitamin E in the treatment of primary dysmenorrhoea." BJOG. 112,4:466-9, 2005. www.womenshealth-elsevier.com/doc/journals/bjog1.html

6. Ziaei S et al. "A randomized placebo-controlled trial to determinethe effect of vitamin E in treatment of primary dysmenorrhoea." BJOG.108, 11:1181-3, 2001. www.womenshealth-elsevier.com/doc/journals/bjog1.html

7. Wuttke W et al. "Chaste tree (Vitex agnus-castus)--pharmacology andclinical indications." Phytomedicine. 10, 4:348-57, 2003. www.urbanfischer.de/journals/frame_template.htm?/journals/phytomed/phytmed.htm

8. Loch EG, Selle H, Boblitz N. "Treatment of premenstrual syndrome witha phytopharmaceutical formulation containing Vitex agnus castus." JWomens Health Gend Based Med. 9, 3:315-20, 2000.

9. Atmaca M, Kumru S, Tezcan E. "Fluoxetine versus Vitex agnus castusextract in the treatment of premenstrual dysphoric disorder." HumPsychopharmacol. 18, 3:191-5, 2003. www.interscience.wiley.com/jpages/0885-6222

10. Kohama T et al. "Analgesic efficacy of French maritime pine barkextract in dysmenorrhea: an open clinical trial." J Reprod Med. 49,10:828-32, 2004.

11. Rossouw JE et al. "Risks and benefits of estrogen plus progestin inhealthy postmenopausal women: principal results from the Women's HealthInitiative randomized controlled trial." JAMA. 288, 3:321-33, 2002. www.jama.ama-assn.org

12. Kelly JP et al. "Use of postmenopausal hormone therapy since theWomen's Health Initiative findings." Pharmacoepidemiol Drug Saf.April 5, 2005 [Epub ahead of print]. www3.interscience.wiley.com/cgi-bin/jhome/5669

13. Mahady GB et al. "Botanical dietary supplement use in peri- andpostmenopausal women." Menopause. 10, 1:65-72, 2003. www.menopausejournal.com

14. North American Menopause Society. "Treatment of menopause-associatedvasomotor symptoms: position statement of The North American MenopauseSociety." Menopause. 11, 1:11-33, 2004. www.menopausejournal.com

15. Kronenberg F, Fugh-Berman A. "Complementary and alternative medicinefor menopausal symptoms: a review of randomized, controlled trials." AnnIntern Med. 137, 10:805-13, 2002. www.annals.org

16. Krebs EE et al. "Phytoestrogens for treatment of menopausalsymptoms: a systematic review." Obstet Gynecol. 104, 4:824-36, 2004.www.greenjournal.org

17. Petri Nahas E et al. "Benefits of soy germ isoflavones inpostmenopausal women with contraindication for conventional hormone replacementtherapy." Maturitas. 48, 4:372-80, 2004. www.sciencedirect.com/science/journal/03785122

18. Colacurci N et al. "Effects of soy isoflavones on menopausalneurovegetative symptoms." Minerva Ginecol. 56, 5:407-12, 2004.

19. Rosell MS et al. "Soy intake and blood cholesterol concentrations: across-sectional study of 1033 pre- and postmenopausal women in the Oxford arm ofthe European Prospective Investigation into Cancer and Nutrition." Am JClin Nutr. 80, 5:1391-6, 2004. www.ajcn.org

20. Zhan S, Ho SC. "Meta-analysis of the effects of soy proteincontaining isoflavones on the lipid profile." Am J Clin Nutr. 81,2:397-408, 2005. www.ajcn.org

21. Engelman HM et al. "Blood lipid and oxidative stress responses tosoy protein with isoflavones and phytic acid in postmenopausal women." AmJ Clin Nutr. 81, 3:590-6, 2005. www.ajcn.org

22. Blum A et al. "Effects of soy protein on endothelium-dependentvasodilatation and lipid profile in postmenopausal women with mildhypercholesterolemia." Clin Invest Med. 26, 1:20-6, 2003.

23. Kreijkamp-Kaspers S et al. "Randomized controlled trial of theeffects of soy protein containing isoflavones on vascular function inpostmenopausal women." Am J Clin Nutr. 81, 1:189-95, 2005. www.ajcn.org

24. Steinberg FM et al. "Soy protein with isoflavones has favorableeffects on endothelial function that are independent of lipid and antioxidanteffects in healthy postmenopausal women." Am J Clin Nutr. 78,1:123-30, 2003. www.ajcn.org

25. Cuevas AM et al. "Isolated soy protein improves endothelial functionin postmenopausal hypercholesterolemic women." Eur J Clin Nutr. 57,8:889-94, 2003. www.naturesj.com/ejcn

26. Upmalis DH et al. "Vasomotor symptom relief by soy isoflavoneextract tablets in postmenopausal women: a multicenter, double-blind,randomized, placebo-controlled study." Menopause. 7, 4:236-42, 2000.www.menopausejournal.com

27. Scambia G et al. "Clinical effects of a standardized soy extract inpostmenopausal women: a pilot study." Menopause. 7, 2:105-11, 2000. www.menopausejournal.com

28. Setchell KD et al. "Pharmacokinetics of a slow-release formulationof soybean isoflavones in healthy postmenopausal women." J Agric FoodChem. 53, 6:1938-44, 2005. http://pubs.acs.org/journals/jafcau

29. Kliger B. "Black cohosh." Am Fam Physician. 68:114-6, 2003www.aafp.org/afp

30. Huntley A. "The safety of black cohosh (Actaea racemosa,Cimicifuga racemosa)." Expert Opin Drug Saf. 3, 6:615-23, 2004. http://puck.ashley-pub.com/vl=851608/cl=24/nw=1/rpsv/journal/journal3_home.htm

31. Pockaj BA et al. "Pilot evaluation of black cohosh for the treatmentof hot flashes in women." Cancer Invest. 22, 4:515-21, 2004.

32. Wuttke W, Seidlova-Wuttke D, Gorkow C. "The Cimicifuga preparationBNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study:effects on menopause symptoms and bone markers." Maturitas. 44 Suppl1:S67-77, 2003. www.sciencedirect.com/science/journal/03785122

33. Lupu R et al. "Black cohosh, a menopausal remedy, does not haveestrogenic activity and does not promote breast cancer cell growth." IntJ Oncol. 23, 5:1407-12, 2003. www.erlbaum.com/Journals/journals/NC/nc.htm

34. Bodinet C, Freudenstein J. "Influence of marketed herbal menopausepreparations on MCF-7 cell proliferation." Menopause. 11, 3:281-9,2004. www.menopausejournal.com

35. Tice JA et al. "Phytoestrogen supplements for the treatment of hotflashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlledtrial." JAMA. 290, 2:207-14, 2003. www.jama.ama-assn.org

36. van de Weijer PH, Barentsen R. "Isoflavones from red clover(Promensil) significantly reduce menopausal hot flush symptoms compared withplacebo." Maturitas. 42, 3:187-93, 2002. www.sciencedirect.com/science/journal/03785122

37. Kupfersztain C et al. "The immediate effect of natural plantextract, Angelica sinensis and Matricaria chamomilla (Climex) for the treatmentof hot flushes during menopause. A preliminary report." Clin Exp ObstetGynecol. 30, 4:203-6, 2003.

38. Bagchi D et al. "Phytoestrogen, resveratrol and women'shealth." Res Commun Pharmacol Toxicol. 5, 1-2:107-21, 2000.

39. Bagchi D et al. "Benefits of resveratrol in women's health." DrugsExp Clin Res. 27, 5-6:233-48, 2001.

40. Mokbel K. "Risk-reducing strategies for breast cancer--a review ofrecent literature." Int J Fertil Womens Med. 48, 6:274-7, 2003.

41. Fleischauer AT, Simonsen N, Arab L. "Antioxidant supplements andrisk of breast cancer recurrence and breast cancer-related mortality amongpostmenopausal women." Nutr Cancer. 46, 1:15-22, 2003. www.erlbaum.com/Journals/journals/NC/nc.htm

42. Branda RF et al. "Effect of vitamin B12, folate, and dietarysupplements on breast carcinoma chemotherapy--induced mucositis andneutropenia." Cancer. 101, 5:1058-64, 2004. www.interscience.wiley.com/jpages/0008-543X

43. Sylvester PW, Shah SJ. "Mechanisms mediating the antiproliferativeand apoptotic effects of vitamin E in mammary cancer cells." FrontBiosci. 10:699-709, 2005. www.bioscience.org

44. Zhang SM. "Role of vitamins in the risk, prevention, and treatmentof breast cancer." Curr Opin Obstet Gynecol. 16, 1:19-25, 2004. www.co-obgyn.com

45. Zhang SM et al. "Plasma folate, vitamin B6, vitamin B12,homocysteine, and risk of breast cancer." J Natl Cancer Inst. 95,5:373-80, 2003.

46. Shrubsole MJ et al. "Dietary folate intake and breast cancer risk:results from the Shanghai Breast Cancer Study." Cancer Res. 61,19:7136-41, 2001. http://cancerres.aacrjournals.org

47. Tamimi RM et al. "Plasma carotenoids, retinol, and tocopherols andrisk of breast cancer." Am J Epidemiol. 161, 2:153-60, 2005. www.aje.oupjournals.org

48. Sato R et al. "Prospective study of carotenoids, tocopherols, andretinoid concentrations and the risk of breast cancer." Cancer EpidemiolBiomarkers Prev. 11, 5:451-7, 2002. http://cebp.aacrjournals.org/

49. Bosetti C et al. "Flavonoids and breast cancer risk in Italy." CancerEpidemiol Biomarkers Prev. 14, 4:805-8, 2005. http://cebp.aacrjournals.org/

50. Peterson J et al. "Flavonoid intake and breast cancer risk: acase--control study in Greece." Br J Cancer. 89, 7:1255-9, 2003. www.nature.com/bjc/index.html

51. Kim H et al. "Chemoprevention by grape seed extract and genistein incarcinogen-induced mammary cancer in rats is diet dependent." J Nutr.134, 12 Suppl:3445S-3452S, 2004. www.nutrition.org

52. Eng ET et al. "Suppression of estrogen biosynthesis by procyanidindimers in red wine and grape seeds." Cancer Res. 63, 23:8516-22,2003. http://cancerres.aacrjournals.org

53. Banerjee S, Bueso-Ramos C, Aggarwal BB. "Suppression of7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats byresveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrixmetalloprotease 9." Cancer Res. 62, 17:4945-54, 2002. http://cancerres.aacrjournals.org

54. Wu AH et al. "Green tea and risk of breast cancer in AsianAmericans." Int J Cancer. 106, 4:574-9, 2003. www3.interscience.wiley.com

55. Yuan JM et al. "Green tea intake, ACE gene polymorphism and breastcancer risk among Chinese women in Singapore." Carcinogenesis. March31, 2005 [Epub ahead of print]. http://carcin.oupjournals.org

56. Vergote D et al. "(-)-Epigallocatechin (EGC) of green tea inducesapoptosis of human breast cancer cells but not of their normalcounterparts." Breast Cancer Res Treat. 76, 3:195-201, 2002. www.springerlink.com/link.asp?id=102860

57. Zhou JR et al. "Combined inhibition of estrogen-dependent humanbreast carcinoma by soy and tea bioactive components in mice." Int JCancer. 108, 1:8-14, 2004. www3.interscience.wiley.com

58. Yan L, Spitznagel E. "A meta-analysis of soyfoods and risk of breastcancer in women." Int J Cancer Prev. 1, 4:281-93, 2005.

59. Badger TM et al. "Soy protein isolate and protection againstcancer." J Am Coll Nutr. 24, 2:146S-149S, 2005. www.am-coll-nutr.org/jacn/jacn.htm

60. McCann SE et al. "Dietary lignan intakes and risk of pre- andpostmenopausal breast cancer." Int J Cancer. 111, 3:440-3, 2004. www3.interscience.wiley.com

61. Haggans CJ et al. "The effect of flaxseed and wheat bran consumptionon urinary estrogen metabolites in premenopausal women." CancerEpidemiol Biomarkers Prev. 9:719-25, 2000. http://cebp.aacrjournals.org/

62. Thompson LU et al. "Biological effects of dietary flaxseed inpatients with breast cancer." Breast Cancer Res Treat. 64:50, 2000. www.springerlink.com/link.asp?id=102860

63. Chen J, Thompson LU. "Lignans and tamoxifen, alone or incombination, reduce human breast cancer cell adhesion, invasion and migration invitro." Breast Cancer Res Treat. 80, 2:163-70, 2003. www.springerlink.com/link.asp?id=102860

64. Kemp MQ, Jeffy BD, Romagnolo DF. "Conjugated linoleic acid inhibitscell proliferation through a p53-dependent mechanism: effects on the expressionof G1-restriction points in breast and colon cancer cells." J Nutr.133, 11:3670-7, 2003. www.nutrition.org

65. Masso-Welch PA et al. "Isomers of conjugated linoleic acid differ intheir effects on angiogenesis and survival of mouse mammary adiposevasculature." J Nutr. 134, 2:299-307, 2004. www.nutrition.org

66. Lavillonniere F et al. "Dietary purified cis-9,trans-11 conjugatedlinoleic acid isomer has anticarcinogenic properties in chemically inducedmammary tumors in rats." Nutr Cancer. 45, 2:190-4, 2003. www.erlbaum.com/Journals/journals/NC/nc.htm

67. Hubbard NE, Lim D, Erickson KL. "Effect of separate conjugatedlinoleic acid isomers on murine mammary tumorigenesis." Cancer Lett.190, 1:13-9, 2003. www.elsevier.com/locate/canlet

68. Tantivejkul K, Vucenik I, Shamsuddin AM. "Inositol hexaphosphate(IP6) inhibits key events of cancer metastasis: I. In vitro studies of adhesion,migration and invasion of MDA-MB 231 human breast cancer cells." AnticancerRes. 23, 5A:3671-9, 2003. www.geocities.com/Athens/Rhodes/8729/iiar/iiar.htm

69. Tantivejkul K, Vucenik I, Shamsuddin AM. "Inositol hexaphosphate(IP6) inhibits key events of cancer metastasis: II. Effects on integrins andfocal adhesions." Anticancer Res. 23, 5A:3681-9, 2003. www.geocities.com/Athens/Rhodes/8729/iiar/iiar.htm

70. Tantivejkul K et al. "Inositol hexaphosphate (IP6) enhances theanti-proliferative effects of adriamycin and tamoxifen in breast cancer." BreastCancer Res Treat. 79, 3:301-12, 2003. www.springerlink.com/link.asp?id=102860

71. Coxam V. "[New advances in osteoporosis nutritionalprevention.]" Med Sci (Paris). 21, 3:297-301, 2005.

72. Deplas A et al. "Bone density, parathyroid hormone, calcium andvitamin D nutritional status of institutionalized elderly subjects." JNutr Health Aging. 8, 5:400-4, 2004. www.springerpub.com

73. Holick MF et al. "Prevalence of vitamin D inadequacy amongpostmenopausal North American women receiving osteoporosis therapy." JClin Endocrinol Metab. March 29, 2005 [Epub ahead of print]. http://jcem.endojournals.org

74. Malabanan AO, Holick MF. "Vitamin D and bone health inpostmenopausal women." J Womens Health (Larchmt). 12, 2:151-6, 2003.www.liebertonline.com/loi/jwh

75. Di Daniele N et al. "Effect of supplementation of calcium andvitamin D on bone mineral density and bone mineral content in peri- andpost-menopause women; a double-blind, randomized, controlled trial." PharmacolRes. 50, 6:637-41, 2004. www.sciencedirect.com/science/journal/10436618

76. Nieves JW. "Calcium, vitamin D, and nutrition in elderlyadults." Clin Geriatr Med. 19, 2:321-35, 2003.

77. Heaney RP, Rafferty K, Dowell MS. "Effect of yogurt on a urinarymarker of bone resorption in postmenopausal women." J Am Diet Assoc.102, 11:1672-4, 2002. www.adajournal.org

78. Narva M et al. "The effect of Lactobacillus helveticus fermentedmilk on acute changes in calcium metabolism in postmenopausal women." EurJ Nutr. 43, 2:61-8, 2004. http://link.springer.de/link/service/journals/00394/

79. Rao LG, Khan T. "TK." 31st European Symposium on CalcifiedTissues, Nice, France, June 5-9, 2004.

80. Tucker KL. "Dietary intake and bone status with aging." CurrPharm Des. 9, 32:2687-704, 2003.

81. Maurer J et al. "Dietary iron positively influences bone mineraldensity in postmenopausal women on hormone replacement therapy." J Nutr.135, 4:863-9, 2005. www.nutrition.org

82. Harris MM et al. "Dietary iron is associated with bone mineraldensity in healthy postmenopausal women." J Nutr. 133, 11:3598-602,2003. www.nutrition.org

83. Arjmandi BH et al. "Soy protein has a greater effect on bone inpostmenopausal women not on hormone replacement therapy, as evidenced byreducing bone resorption and urinary calcium excretion." J ClinEndocrinol Metab. 88, 3:1048-54, 2003. http://jcem.endojournals.org

84. Ho SC et al. "Soy protein consumption and bone mass in earlypostmenopausal Chinese women." Osteoporos Int. 14, 10:835-42, 2003. www.link.springer.de/link/service/journals/00198

85. Lydeking-Olsen E et al. "Soymilk or progesterone for prevention ofbone loss--a 2 year randomized, placebo-controlled trial." Eur J Nutr.43, 4:246-57, 2004. http://link.springer.de/link/service/journals/00394/

86. Kreijkamp-Kaspers S et al. "Effect of soy protein containingisoflavones on cognitive function, bone mineral density, and plasma lipids inpostmenopausal women: a randomized controlled trial." JAMA. 292,1:65-74, 2004. www.jama.ama-assn.org

87. Harkness LS et al. "Decreased bone resorption with soy isoflavonesupplementation in postmenopausal women." J Womens Health (Larchmt).13, 9:1000-7, 2004. www.liebertonline.com/loi/jwh

88. Chen YM et al. "Beneficial effect of soy isoflavones on bone mineralcontent was modified by years since menopause, body weight, and calcium intake:a double-blind, randomized, controlled trial." Menopause. 11,3:246-54, 2004. www.menopausejournal.com

89. Mathey JP et al. "Fructooligosaccharides maximize bone-sparingeffects of soy isoflavone-enriched diet in the ovarietomized rat." CalcifTissue Int. 75, 2:169-79, 2004. http://link.springer.de/link/service/journals/00223/

90. Ohta A et al. "A combination of dietary fructooligosaccharides andisoflavone conjugates increases femoral bone mineral density and equolproduction in ovariectomized mice." J Nutr. 132, 7:2049-54, 2002. www.nutrition.org

91. Katsuyama H et al. "Promotion of bone formation by fermented soybean(Natto) intake in premenopausal women." J Nutr Sci Vitaminol (Tokyo).50, 2:114-20, 2004.

92. Katsuyama H et al. "Usual dietary intake of fermented soybeans(Natto) is associated with bone mineral density in premenopausal women." JNutr Sci Vitaminol (Tokyo). 48, 3:207-15, 2002.

93. SOGC. "The detection and management of vaginal atrophy." IntJ Gynaecol Obstet. 88, 2:222-8, 2005. www.elsevier.nl/inca/publications/store/5/0/6/0/3/7

94. Jepson RG, Mihaljevic L, Craig J. "Cranberries for preventingurinary tract infections." Cochrane Database Syst Rev. 2:CD001321,2004. www.cochrane.org

95. Raz R, Chazan B, Dan M. "[Cranberry juice and urinary tractinfection.]" Harefuah. 143, 12:891-4, 909, 2004.

96. Kontiokari T et al. "Randomized trial of cranberry-lingonberry juiceand Lactobacillus GG drink for the prevention of urinary tract infections inwomen." BMJ. 322, 7302:1571, 2001. http://bmj.com

97. Stothers L. "A randomized trial to evaluate effectiveness and costeffectiveness of naturopathic cranberry products as prophylaxis against urinarytract infection in women." Can J Urol. 9, 3:1558-62, 2002.

98. Reid G, Burton J, Devillard E. "The rationale for probiotics infemale urogenital healthcare." MedGenMed. 6, 1:49, 2004. www.medscape.com/pages/homepages/ejournal/mgm

99. Reid G et al. "Nucleic acid-based diagnosis of bacterial vaginosisand improved management using probiotic lactobacilli." J Med Food.7, 2:223-8, 2004. www.liebertpub.com

100. Reid G et al. "Oral use of Lactobacillus rhamnosus GR-1 and L.fermentum RC-14 significantly alters vaginal flora: randomized,placebo-controlled trial in 64 healthy women." FEMS Immunol MedMicrobiol. 35, 2:131-4, 2003.

101. Reid G et al. "Probiotic Lactobacillus dose required to restore andmaintain a normal vaginal flora." FEMS Immunol Med Microbiol. 32,1:37-41, 2001.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like